CN Patent

CN114685537A — 丁苯酞衍生物g-3702在制备脑缺血再灌注损伤预防和治疗药物中的应用

Assigned to Nanjing University of Science and Technology · Expires 2022-07-01 · 4y expired

What this patent protects

本发明公开了一种丁苯酞衍生物G‑3702在制备脑缺血再灌注损伤预防和治疗药物中的应用。所述的丁苯酞衍生物G‑3702的结构式为 本发明的G‑3702具有显著的抗脑缺血再灌注损伤的作用，且效果优于能显著改善缺血性脑卒中患者的中枢神经功能损伤的丁苯酞，可以用于制备脑缺血再灌注损伤的预防和治疗药物。

USPTO Abstract

本发明公开了一种丁苯酞衍生物G‑3702在制备脑缺血再灌注损伤预防和治疗药物中的应用。所述的丁苯酞衍生物G‑3702的结构式为 本发明的G‑3702具有显著的抗脑缺血再灌注损伤的作用，且效果优于能显著改善缺血性脑卒中患者的中枢神经功能损伤的丁苯酞，可以用于制备脑缺血再灌注损伤的预防和治疗药物。

Drugs covered by this patent

Patent Metadata

Patent number
CN114685537A
Jurisdiction
CN
Classification
—
Expires
2022-07-01
Drug substance claim
No
Drug product claim
No
Assignee
Nanjing University of Science and Technology
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.